Because our injections bypass the digestive tract, they offer 100% bioavailability, ensuring your body receives the full dose of energy-boosting nutrients immediately
However, they are not FDA-approved for any human therapeutic use, and long-term safety data is limited
This reduces potential confounding factors in research and provides a highly specific tool for metabolic studies
Semaglutide is offered in staged dosing, starting with the first-stage protocol and moving up under supervision
Dosing & Reconstitution Guide Educational guide for reconstitution and daily dosing Subcutaneous Protocol (4 mL = 12.5 mg/mL) Frequency: Inject once or twice daily subcutaneously
In reproductive tissues, peptides may originate endogenously, released during normal physiology or injury, or from exogenously applied preparations intended to simulate or stimulate those signals